First published data backs CanSino’s inhaled COVID vaccineEarly-stage clinical data with CanSino Biologics’ inhaled COVID-19 vaccine show that it was able to stimulate neutralising antibodies Share XFirst published data backs CanSino’s inhaled COVID vaccinehttps://pharmaphorum.com/news/first-published-data-backs-cansinos-inhaled-covid-vaccine/
Losing ground in COVID-19 vaccine race, CanSino turns to RussiaPoliticking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics, but Share XLosing ground in COVID-19 vaccine race, CanSino turns to Russiahttps://pharmaphorum.com/news/losing-ground-in-covid-19-vaccine-race-cansino-turns-to-russia/
‘Promising’ data on Oxford/AZ, CanSino coronavirus vaccinesData from more than 1,000 healthy volunteers dosed with a coronavirus vaccine developed at Oxford University and AstraZeneca Share X‘Promising’ data on Oxford/AZ, CanSino coronavirus vaccineshttps://pharmaphorum.com/news/first-data-on-oxford-astrazeneca-cansino-coronavirus-vaccines-promising/
Inovio begins clinical trial of COVID-19 vaccineUS-based Inovio has become the third biotech to begin clinical development of a vaccine against the COVID-19 coronavirus. Share XInovio begins clinical trial of COVID-19 vaccinehttps://pharmaphorum.com/news/inovio-begins-clinical-trial-of-covid-19-vaccine/
